Gilead Sciences, Inc. Price Today
Gilead Sciences, Inc.
GILD
Healthcare
$86.56B
💰
Market Cap
15.4
💸
Price to Earnings
$4.5
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
12 |
Strong Buy |
6 |
Hold |
19 |
Sell |
1 |
Strong Sell |
0 |
GILD Price Forecast Target
69.4 👉 111.5 +61%
GILD EPS Forecast
4.5 👉 6.8 +52%
Financials
Profit Margin
21 %
Revenue Growth
-3.7 %
Dividend
$ 3.08
Held Percent
0.1% - Insiders
88.4% - Institutions
11.5% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
Bill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly conc…
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…📮FAQ
Some Frequently Asked Questions.
The Gilead Sciences, Inc. industry is Drug Manufacturers—General
The Gilead Sciences, Inc. sector is Healthcare
The Gilead Sciences, Inc. forecasted predicted Price to Earnings PE ratio is 10.1
The Gilead Sciences, Inc. Price to Earnings PE ratio is 15.4
The Market Capitalization of Gilead Sciences, Inc. is $86.56B
There are total of 1243146032 float shares with 88.4% held by Institutions and 0.1% held by insiders
The MGilead Sciences, Inc. forecasted Earnings per Share EPS is $6.8
The Gilead Sciences, Inc. Earnings per Share EPS is 4.5
The Gilead Sciences, Inc. company has $0 gross profits with 21 profit margins
The Gilead Sciences, Inc. Earnings Growth is -0.131% with -0.129% quarterly earnings growth
The Gilead Sciences, Inc. Revenue is $27115999232 with -0.037 revenue growth
The price target for Gilead Sciences, Inc. stock is $111.5 for the high target and $63.6 for the low target
The consensus analyst recommendations for Gilead Sciences, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Gilead Sciences, Inc. is Buy, with the following breakdown:
- Buy: 12
- Strong Buy: 6
- Hold: 19
- Sell: 1
- Strong Sell: 0
The Beta of Gilead Sciences, Inc. is 0.2
The dividend of Gilead Sciences, Inc. is $3.08
The dividend yield of Gilead Sciences, Inc. is 0.0444%
The biggest institutional and mutual fund holders of Gilead Sciences, Inc. stock are
The Gilead Sciences, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0